News | August 07, 2007

CyberKnife's Extracranial Treatment Growth Indicates Possible Radiosurgery Market Shift

August 8, 2007 – Accuray Inc. announced that use of its CyberKnife Robotic Radiosurgery System to noninvasively treat extracranial tumors has increased 75 percent in 2007.

The number of lung cancer patients treated with the system doubled, while the number of prostate cancer procedures with the system quadrupled over the past year.

Radiosurgery has historically been used exclusively for the treatment of brain tumors. The CyberKnife System, however, is FDA cleared to treat tumors anywhere in the body, including the spine, lungs, prostate, liver and pancreas.

Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment, the company says. This enables the CyberKnife System to deliver precise, high-dose radiation, minimizing damage to surrounding healthy tissue and eliminating the need for invasive head or body stabilization frames.

“The CyberKnife System has revolutionized cancer care. We are now able to treat a wide array of tumors, including many that were untreatable in the past," said Dr. Greg Gagnon, associate professor, interim chairman of the Department of Radiation Medicine and CyberKnife Program Director at Georgetown University Hospital in Washington, DC. "Because it is noninvasive and delivers high-dose radiation with sub-millimeter accuracy, the CyberKnife System is a perfect tool for destroying tumors quickly with minimal side effects."

For more information: www.accuray.com.

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...
Videos | Treatment Planning | August 28, 2018
A discussion with...
Sponsored Content | Webinar | Radiation Therapy | August 28, 2018
Respiratory tumor motion often complicates the delivery of precision radiation treatment.
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...
Videos | Radiation Therapy | August 13, 2018
ITN Editor Dave Fornell takes a tour of some of the innovative new technologies on the expo floor at the 2018 America